1. Home
  2. EVAX vs JTAI Comparison

EVAX vs JTAI Comparison

Compare EVAX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • JTAI
  • Stock Information
  • Founded
  • EVAX 2008
  • JTAI 2018
  • Country
  • EVAX Denmark
  • JTAI United States
  • Employees
  • EVAX N/A
  • JTAI N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • JTAI Blank Checks
  • Sector
  • EVAX Health Care
  • JTAI Finance
  • Exchange
  • EVAX Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • EVAX 8.7M
  • JTAI 7.1M
  • IPO Year
  • EVAX 2021
  • JTAI N/A
  • Fundamental
  • Price
  • EVAX $2.49
  • JTAI $6.03
  • Analyst Decision
  • EVAX Strong Buy
  • JTAI
  • Analyst Count
  • EVAX 3
  • JTAI 0
  • Target Price
  • EVAX $33.33
  • JTAI N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • JTAI 5.3M
  • Earning Date
  • EVAX 03-26-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • EVAX N/A
  • JTAI N/A
  • EPS Growth
  • EVAX N/A
  • JTAI N/A
  • EPS
  • EVAX N/A
  • JTAI N/A
  • Revenue
  • EVAX $3,295,000.00
  • JTAI $15,028,926.00
  • Revenue This Year
  • EVAX $9,039.73
  • JTAI $21.49
  • Revenue Next Year
  • EVAX $1.47
  • JTAI $10.05
  • P/E Ratio
  • EVAX N/A
  • JTAI N/A
  • Revenue Growth
  • EVAX N/A
  • JTAI 46.66
  • 52 Week Low
  • EVAX $2.22
  • JTAI $2.30
  • 52 Week High
  • EVAX $22.50
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 39.85
  • JTAI 74.40
  • Support Level
  • EVAX $2.30
  • JTAI $2.35
  • Resistance Level
  • EVAX $2.80
  • JTAI $2.61
  • Average True Range (ATR)
  • EVAX 0.51
  • JTAI 0.42
  • MACD
  • EVAX 0.03
  • JTAI 0.30
  • Stochastic Oscillator
  • EVAX 6.97
  • JTAI 63.22

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: